Colin Kelley
Chief Financial Officer

Colin Kelley is the Chief Financial Officer of Parrot.MD where he oversees finance, investor relations, and corporate development. 

 

Mr. Kelley is also a Senior Operating Partner for Merida Capital Partners, one of the largest cannabis centric private equity funds.  He is a board member of Brytemap Software, Great White Industries, The Kind Group, and Nautilus Botanicals. Kelley also serves on the editorial board for Cannabis Business Times and is a frequent public speaker on the topics of leadership and entrepreneurship.   

 

Prior to Parrot.MD Mr. Kelley served as a board member, Chief Financial Officer, and Chief Operating Officer of LeafLine Labs; where he oversaw the sale of the company in 2021. Additionally, he has held management roles at Dun & Bradstreet, Investors Bank & Trust, Wind River Capital Management, and Fresenius Medical Care.  He has consulted to the Civilian Research & Development Fund regarding the denuclearization of Libya. Mr. Kelley earned his BSBA in Management and Finance from Bryant University in Rhode Island.